ARTICLE | Clinical News
Foresight Biotherapeutics preclinical data
July 13, 2009 7:00 AM UTC
In rabbits, topical FST-100 significantly reduced signs of adenoviral conjunctivitis compared with topical Vistide cidofovir; dexamethasone plus tobramycin; and placebo. Eyes were scored daily for co...